ClinicalTrials.gov
public full text
Public Domain
Orlistat Reduces Uric Acid in Overweight/Obese Patients With Hyperuricemia
To clarify the uric acid-lowering efficacy of orlistat in overweight/obese patients with hyperuricemia, and to evaluate the safety of orlistat treatment
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Metabolic Impact of Dietary Protein Supplementation in Surgical Weight Loss#872498
- Aerosol Therapy in Obese COPD Patients.#1173910
- The Effect of Diluted Sodium Hypochlorite Solution and Moisturizers on Skin Barrier Function in Atopic Dermatitis#884200
- Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer#980997
- A Phase II Clinical Study Evaluating of ZL-82 Tablets in Atopic Dermatitis#1281413
Record · ID 1409146
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive